分辨率为1.8埃时，胰腺分泌型胰蛋白酶抑制剂（卡扎尔型）与胰蛋白酶原复合物的三维结构。结构解析、晶体学精修及初步结构阐释。 - Suppr

Suppr

超能文献

Three-dimensional structure of the complex between pancreatic secretory trypsin inhibitor (Kazal type) and trypsinogen at 1.8 A resolution. Structure solution, crystallographic refinement and preliminary structural interpretation.

作者信息

Bolognesi M, Gatti G, Menagatti E, Guarneri M, Marquart M, Papamokos E, Huber R

出版信息

J Mol Biol. 1982 Dec 25;162(4):839-68. doi: 10.1016/0022-2836(82)90550-2.

DOI:10.1016/0022-2836(82)90550-2

PMID:7169635

Abstract

摘要

相似文献

Three-dimensional structure of the complex between pancreatic secretory trypsin inhibitor (Kazal type) and trypsinogen at 1.8 A resolution. Structure solution, crystallographic refinement and preliminary structural interpretation.分辨率为1.8埃时，胰腺分泌型胰蛋白酶抑制剂（卡扎尔型）与胰蛋白酶原复合物的三维结构。结构解析、晶体学精修及初步结构阐释。

J Mol Biol. 1982 Dec 25;162(4):839-68. doi: 10.1016/0022-2836(82)90550-2.

Preliminary crystallographic data for the structure of the complex between Kazal trypsin inhibitor and trypsinogen.Kazal型胰蛋白酶抑制剂与胰蛋白酶原复合物结构的初步晶体学数据。

J Mol Biol. 1981 Jan 25;145(3):603-5. doi: 10.1016/0022-2836(81)90547-7.

Zymogen activation: effect of peptides sequentially related to the bovine beta-trypsin N-terminus on Kazal inhibitor and benzamidine binding to bovine trypsinogen.酶原激活：与牛β-胰蛋白酶N端序列相关的肽对卡扎尔抑制剂和苯甲脒与牛胰蛋白酶原结合的影响

J Mol Recognit. 1988 Jun;1(3):130-7. doi: 10.1002/jmr.300010306.

Three-dimensional structure of a recombinant variant of human pancreatic secretory trypsin inhibitor (Kazal type).人胰腺分泌型胰蛋白酶抑制剂（卡扎尔型）重组变体的三维结构

J Mol Biol. 1992 Jun 20;225(4):1095-103. doi: 10.1016/0022-2836(92)90107-u.

Trypsin activation. Effect of the Ile-Val dipeptide concentration on Kazal inhibitor binding to bovine trypsinogen.胰蛋白酶激活。异亮氨酸-缬氨酸二肽浓度对卡扎尔抑制剂与牛胰蛋白酶原结合的影响。

Biochim Biophys Acta. 1985 Dec 20;832(3):378-82. doi: 10.1016/0167-4838(85)90274-2.

Binding of the bovine pancreatic secretory trypsin inhibitor (Kazal) to bovine serine (pro)enzymes.牛胰分泌型胰蛋白酶抑制剂（卡扎尔型）与牛丝氨酸（原）酶的结合

J Mol Biol. 1987 Nov 5;198(1):129-32. doi: 10.1016/0022-2836(87)90463-3.

Structure of bovine trypsinogen at 1.9 A resolution.分辨率为1.9埃的牛胰蛋白酶原结构。

Biochemistry. 1977 Feb 22;16(4):654-64. doi: 10.1021/bi00623a016.

The transition of bovine trypsinogen to a trypsin-like state upon strong ligand binding. The refined crystal structures of the bovine trypsinogen-pancreatic trypsin inhibitor complex and of its ternary complex with Ile-Val at 1.9 A resolution.强配体结合时牛胰蛋白酶原向类胰蛋白酶状态的转变。牛胰蛋白酶原 - 胰蛋白酶抑制剂复合物及其与异亮氨酸 - 缬氨酸的三元复合物在1.9埃分辨率下的精细晶体结构。

J Mol Biol. 1978 Jan 5;118(1):99-112. doi: 10.1016/0022-2836(78)90246-2.

Crystallographic refinement of Japanese quail ovomucoid, a Kazal-type inhibitor, and model building studies of complexes with serine proteases.日本鹌鹑卵类黏蛋白（一种卡扎尔型抑制剂）的晶体学精修以及与丝氨酸蛋白酶复合物的模型构建研究

J Mol Biol. 1982 Jul 5;158(3):515-37. doi: 10.1016/0022-2836(82)90212-1.

Structure of the complex of Streptomyces griseus protease B and the third domain of the turkey ovomucoid inhibitor at 1.8-A resolution.1.8埃分辨率下灰色链霉菌蛋白酶B与火鸡卵类粘蛋白抑制剂第三结构域复合物的结构

Biochemistry. 1983 Sep 13;22(19):4420-33. doi: 10.1021/bi00288a012.

引用本文的文献

Structural and Biophysical Insights into SPINK1 Bound to Human Cationic Trypsin.人阳离子胰蛋白酶结合的丝氨酸蛋白酶抑制剂 Kazal 型 1 的结构和生物物理研究进展

Int J Mol Sci. 2022 Mar 23;23(7):3468. doi: 10.3390/ijms23073468.

Bad Tumors Made Worse: SPINK1.恶性肿瘤恶化：丝氨酸蛋白酶抑制剂Kazal型1（SPINK1）

Front Cell Dev Biol. 2019 Feb 4;7:10. doi: 10.3389/fcell.2019.00010. eCollection 2019.

Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers.丝氨酸蛋白酶抑制剂Kazal 1型（SPINK1）在一部分卵巢癌中促进细胞增殖并增强抗失巢凋亡能力。

Oncotarget. 2015 Nov 3;6(34):35737-54. doi: 10.18632/oncotarget.5927.

Trypsinogen activation as observed in accelerated molecular dynamics simulations.在加速分子动力学模拟中观察到的胰蛋白酶原激活。

Protein Sci. 2014 Nov;23(11):1550-8. doi: 10.1002/pro.2532. Epub 2014 Aug 23.

Molecular characterization of two trypsinogens in the orange-spotted grouper, Epinephelus coioides, and their expression in tissues during early development.两种青石斑鱼胰蛋白酶原的分子特征及其在早期发育过程中组织表达。

Fish Physiol Biochem. 2013 Apr;39(2):201-14. doi: 10.1007/s10695-012-9691-4. Epub 2012 Jul 17.

Targeting the autolysis loop of urokinase-type plasminogen activator with conformation-specific monoclonal antibodies.针对尿激酶型纤溶酶原激活物的自溶环的构象特异性单克隆抗体。

Biochem J. 2011 Aug 15;438(1):39-51. doi: 10.1042/BJ20110129.

Disulfide formation as a probe of folding in GroEL-GroES reveals correct formation of long-range bonds and editing of incorrect short-range ones.二硫键形成作为研究GroEL - GroES折叠的探针，揭示了长程键的正确形成以及对错误短程键的编辑。

Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2145-50. doi: 10.1073/pnas.0610989104. Epub 2007 Feb 5.

Organic anion transporting polypeptides of the OATP/SLCO superfamily: identification of new members in nonmammalian species, comparative modeling and a potential transport mode.OATP/SLCO超家族的有机阴离子转运多肽：非哺乳动物物种中新成员的鉴定、比较建模及潜在转运模式

J Membr Biol. 2005 Dec;208(3):213-27. doi: 10.1007/s00232-005-7004-x. Epub 2006 Apr 20.

Urokinase-type plasminogen activator is a preferred substrate of the human epithelium serine protease tryptase epsilon/PRSS22.尿激酶型纤溶酶原激活剂是人类上皮丝氨酸蛋白酶类胰蛋白酶ε/PRSS22的首选底物。

Blood. 2005 May 15;105(10):3893-901. doi: 10.1182/blood-2003-10-3501. Epub 2005 Feb 8.

Identification of furin pro-region determinants involved in folding and activation.鉴定参与折叠和激活的弗林蛋白酶前体区域决定因素。

Biochem J. 2004 May 1;379(Pt 3):757-63. doi: 10.1042/BJ20031902.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验